🇺🇸 FDA
Patent

US 6884413

Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (GCS)

expired A61KA61K35/13A61K40/17

Quick answer

US patent 6884413 (Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (GCS)) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/13, A61K40/17, A61K40/24, A61K40/42